Placebo-Controlled Trial of Cisapride and Nizatidine in Unselected Patients With Functional Dyspepsia

Abstract

The effects of a 2-wk course of cisapride or nizatidine in unselected patients with dyspepsia recruited from primary care were not superior to those of placebo. Symptom subgrouping was not predictive of response to therapy.